15 December 2022 · Understanding the role and responsibilities of the MSO in practice will assist organisations in delivering their medication safety agenda
6 March 2024 · Timely use of rasburicase for treatment of Tumour Lysis Syndrome is essential. Mitigation strategies can minimise harm associated with delayed therapy.
11 June 2024 · A systematic approach should be taken to responding to reports of possible malicious tampering, securing the evidence, and seeking specialist advice and support
25 January 2023 · Suitable medicines must be stored safely and securely in accordance with organisational policy, while still supporting self-administration
13 September 2024 · 3 formulations exist: 1 conventional; 2 liposomal. Conventional and liposomal formulations are not interchangeable; liposomal formulations are interchangeable.
31 July 2018 · Intended audience: This document is intended as a reference and source of information to the following audiences: Nursing staff who handle cytotoxic chemotherapy (Oncology /…
16 March 2021 · Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.